DSIP Peptide 10mg – Protide Health USA

DSIP Peptide Overview & Technical Specifications

DSIP peptide is a synthetic nine-amino-acid peptide commonly known as Delta Sleep-Inducing Peptide.

Its sequence is:

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

or:

WAGGDASGE

The complete terminal representation is:

H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH

Protide Health supplies DSIP peptide as 10mg of 99% purity, HPLC-MS verified, third-party tested lyophilized research material in a 3mL vial.

DSIP has a long research history involving sleep-wake physiology, circadian signaling, neuroendocrine responses, stress models, and other experimental neurophysiological systems. However, the human sleep literature is old, relatively small, and inconsistent, so DSIP should not be represented as an established insomnia treatment.

Technical Specifications

• Product Name: DSIP
• Full Name: Delta Sleep-Inducing Peptide
• Alternative Name: Emideltide
• Quantity: 10mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Purity: 99%
• Testing: HPLC-MS verified; third-party tested
• Peptide Type: Synthetic nonapeptide
• Peptide Length: 9 amino acids
• Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
• One-Letter Sequence: WAGGDASGE
• CAS Number: 62568-57-4
• PubChem CID: 68816
• Molecular Formula: C35H48N10O15
• Molecular Weight: approximately 848.82 g/mol
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in water
• Storage: Store sealed at ≤6°C and protected from heat, light, and moisture
• Research Use: Sleep-wake physiology, circadian signaling, neuropeptide, biochemical, analytical, and qualified preclinical research only

Researchers can reference the supplied DSIP chemical structure.

What Is DSIP Peptide?

DSIP peptide was originally named for experimental observations involving delta-wave sleep.

The name stands for:

Delta Sleep-Inducing Peptide

DSIP was historically isolated and investigated as a possible endogenous sleep-related factor.

Research has subsequently examined DSIP in relation to:

• Sleep architecture
• Sleep onset
• Delta-wave activity
• Circadian physiology
• Neuroendocrine responses
• Stress-related models
• Pain-related signaling
• Neurotransmitter systems

The name “sleep-inducing peptide” should not be interpreted as proof that DSIP is an established human sleep medication.

DSIP Delta Sleep Inducing Peptide Research

The phrase DSIP delta sleep inducing peptide reflects the historical origin of the compound.

A 1984 review described DSIP as a nonapeptide with a molecular weight near 849 Da and summarized experimental sleep-related effects in several animal species and humans.

The review also emphasized that DSIP activity could vary according to:

• Species
• Experimental timing
• Dose
• Circadian phase
• Route of experimental exposure

This variability became an important feature of later DSIP research.

DSIP Peptide & Human Sleep Research

Human DSIP research dates primarily from the 1980s and early 1990s.

An early double-blind crossover study involving six healthy volunteers reported:

• Increased sleep during an observation period
• Shorter subsequent sleep onset
• Reduced stage-1 sleep
• Improved sleep efficiency

These findings generated considerable interest in DSIP peptide as a possible tool for investigating sleep physiology.

However, the study was extremely small, and later controlled research produced less convincing results.

DSIP & Chronic Insomnia Research

Several studies subsequently evaluated DSIP in individuals with chronic insomnia.

A 1987 controlled study found some apparent changes in:

• Nocturnal awakenings
• NREM sleep
• Total sleep time
• Stage-2 sleep

However, many differences were not statistically significant relative to placebo, and some baseline differences complicated interpretation.

The investigators concluded that the observed sleep improvement was of little clinical significance.

This is an important limitation when discussing DSIP peptide benefits.

Double-Blind DSIP Research

A later double-blind study investigated 16 individuals with chronic insomnia.

Objective measures suggested:

• Higher sleep efficiency
• Shorter sleep latency

However, the researchers noted that:

• Effects were weak
• Some changes could have resulted from variation in the placebo group
• Subjective sleep quality did not meaningfully improve
• Most measured sleep variables were unchanged

The investigators concluded that short-term DSIP treatment was unlikely to provide major therapeutic benefit.

For this reason, Protide Health does not present DSIP as a clinically established insomnia peptide.

DSIP Peptide Benefits: Evidence Context

The phrase DSIP peptide benefits commonly appears in consumer searches.

Historical research has examined DSIP in areas including:

• Sleep physiology
• Circadian patterns
• Neuroendocrine signaling
• Stress responses
• Pain-related models
• Neurotransmitter activity

These topics represent research questions rather than established therapeutic benefits.

The available literature does not establish that Protide Health DSIP peptide:

• Treats insomnia
• Improves sleep in humans
• Increases deep sleep reliably
• Treats anxiety
• Treats chronic pain
• Treats withdrawal syndromes
• Improves recovery
• Provides general neurological benefits

The evidence base is too inconsistent and limited to support such claims.

DSIP & Sleep Architecture

Sleep is divided into multiple stages, including:

• NREM stage 1
• NREM stage 2
• Slow-wave sleep
• REM sleep

Despite the name Delta Sleep-Inducing Peptide, controlled studies have not consistently demonstrated a selective increase in slow-wave sleep.

For example, one controlled insomnia study reported increases in total NREM and stage-2 sleep but no meaningful change in slow-wave sleep.

This distinction is important because the peptide’s name can otherwise create an overly simple impression of its pharmacology.

DSIP Peptide & Circadian Research

DSIP has also been investigated as a potential regulator of circadian physiology.

Earlier review literature described experimental effects involving:

• Sleep-wake cycles
• Locomotor patterns
• Body temperature
• Cardiovascular variables
• Hormonal signals
• Neurotransmitter activity

Some effects appeared dependent on the timing of experimental exposure.

This led researchers to propose that DSIP might be useful as a tool for studying physiological processes surrounding sleep onset rather than as a conventional sedative.

DSIP & Neuroendocrine Research

Historical studies have investigated DSIP-associated changes in neuroendocrine pathways.

Reported experimental endpoints have included:

• Cortisol
• Neurotransmitter concentrations
• Circadian hormone patterns
• Stress-related endocrine responses

These observations are heterogeneous and arise from older experimental literature.

They do not establish a defined receptor-mediated endocrine mechanism comparable with well-characterized peptide hormones.

DSIP Mechanism of Action: Evidence Limitations

A definitive single receptor mechanism for DSIP peptide has not been established.

This is an important difference from peptides with clearly identified receptors such as:

• Kisspeptin/KISS1R
• Ipamorelin/GHS-R1a
• GLP-2/GLP2R

DSIP literature instead describes a broad range of neurophysiological effects without establishing one universally accepted molecular target.

Researchers should therefore avoid reducing DSIP pharmacology to a single receptor pathway.

DSIP Peptide Dosage Search Context

The phrase DSIP peptide dosage generally concerns human administration.

Protide Health does not provide human dosing instructions.

The 10mg specification describes the total amount of laboratory research material contained in the vial.

It is not a recommended human dose.

No instructions are provided for:

• Human injection
• Intravenous administration
• Daily dosing
• Bedtime dosing
• Sleep protocols
• Body-weight calculations
• Treatment cycles
• Reconstitution for human use

Historical clinical-study amounts should not be converted into self-administration guidance for independently supplied laboratory material.

DSIP Dosage Search Context

The keyword DSIP dosage refers to the same human-use intent.

Older published experiments used highly controlled research protocols in small groups of participants.

Those protocols involved:

• Defined clinical formulations
• Medical supervision
• Controlled study conditions
• Specific experimental endpoints

They do not establish an appropriate DSIP dosage for independently sourced research material.

Protide Health therefore provides no human dosing recommendation.

DSIP Dosing Search Context

The phrase DSIP dosing is also commonly used to search for human administration schedules.

No human administration schedule is provided here.

Qualified laboratory researchers should instead determine experimental concentrations according to:

• Study model
• Assay type
• Cell system
• Exposure duration
• Analytical endpoint
• Published methodology
• Appropriate control groups

DSIP Reddit Search Context

The keyword DSIP Reddit commonly leads to anecdotal discussions involving sleep, dosing, and personal experiences.

Reddit posts may include:

• Subjective sleep reports
• Unverified dosing information
• Product-source recommendations
• Self-experimentation reports
• Unsupported safety conclusions

Such discussions are not controlled scientific evidence.

Because formal DSIP studies already show inconsistent results, anecdotal reports should be interpreted particularly cautiously.

DSIP Peptide Reddit Search Context

The phrase DSIP peptide Reddit represents similar community-generated search intent.

Individual experiences cannot reliably determine:

• Peptide identity
• Purity
• Dose accuracy
• Placebo effects
• Sleep architecture
• Safety
• Long-term outcomes

Objective polysomnographic studies and peer-reviewed research provide a stronger basis for evaluating DSIP physiology.

DSIP & Stress-Response Research

Historical DSIP literature has also explored stress-associated physiology.

Animal experiments and older human observations have examined:

• Stress adaptation
• Cortisol-related responses
• Neuroendocrine changes
• Behavioral responses
• Physiological stress markers

These findings contributed to theories that DSIP might have broader physiological functions beyond sleep.

However, those theories remain less well characterized than established peptide-receptor systems.

DSIP & Pain Research

Older pilot research also investigated DSIP in small groups with chronic pain conditions.

Some improvements were reported in these uncontrolled or minimally controlled studies.

However, these experiments involved very small populations and do not establish DSIP as an analgesic treatment.

Protide Health therefore makes no pain-treatment claim for DSIP peptide.

DSIP & Withdrawal Research

Historical literature also investigated DSIP in withdrawal-related settings.

One older report described experimental use in patients experiencing alcohol- or opioid-related withdrawal symptoms.

Those observations belong to early exploratory clinical literature and should not be interpreted as evidence supporting use of research-grade DSIP for withdrawal management.

Modern withdrawal treatment requires established medical protocols and professional supervision.

DSIP vs Conventional Sleep Agents

DSIP is structurally and mechanistically different from conventional hypnotic or sedative drugs.

It is a nine-amino-acid peptide rather than:

• A benzodiazepine
• A Z-drug
• A melatonin-receptor agonist
• An orexin antagonist
• A sedating antihistamine

The uncertain molecular mechanism and inconsistent sleep outcomes make direct therapeutic comparisons inappropriate.

DSIP Research Applications

Qualified laboratories may investigate DSIP peptide in models involving:

• Sleep-wake physiology
• Circadian signaling
• Sleep-onset mechanisms
• Neuroendocrine responses
• Neuropeptide biology
• Stress-related experimental systems
• Neurotransmitter-associated models
• Comparative peptide research
• Analytical peptide characterization

Appropriate controls should be used because DSIP responses can vary considerably by experimental conditions.

Related Protide Health Research Products

Researchers comparing DSIP with other peptide research systems may review the BPC-157 + TB-500 + MOTS-c Research Bundle for a mechanistically distinct multi-peptide research formulation.

The Tesamorelin + Ipamorelin + BPC-157 + TB-500 Research Bundle provides a separate combination spanning endocrine, vascular, and cytoskeletal research pathways.

Researchers may also examine Selank N-Acetyl Amidate 10mg for a structurally distinct modified peptide investigated in neurochemical research models.

These products should not be considered chemically or mechanistically interchangeable with DSIP peptide.

Research Format & Storage

Protide Health supplies DSIP peptide as:

• Quantity: 10mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Purity: 99%
• Testing: HPLC-MS verified
• Verification: Third-party tested
• Appearance: White to off-white
• Solubility: Soluble in water

Storage specifications:

• Store at ≤6°C
• Keep sealed
• Protect from heat
• Protect from direct light
• Protect from moisture

These specifications describe laboratory storage characteristics only.

Research Limitations

Several limitations should be considered when interpreting DSIP research:

• Much of the human literature dates from the 1980s and early 1990s.
• Human studies generally involved very small sample sizes.
• Sleep-related results have been inconsistent.
• Some controlled studies reported only weak effects.
• One double-blind chronic-insomnia trial concluded that major therapeutic benefit was unlikely.
• Slow-wave sleep has not been consistently increased despite the peptide’s name.
• A definitive single molecular receptor has not been established.
• Pain, stress, and withdrawal literature is exploratory and old.
• Reddit reports are anecdotal rather than controlled evidence.
• The 10mg quantity represents vial contents, not a human dose.
• Protide Health DSIP is not an FDA-approved sleep medication or pharmaceutical product.

For these reasons, DSIP peptide is supplied strictly for qualified laboratory research.

Literature & Citation Index

Delta-Sleep-Inducing Peptide (DSIP): A Review

Year: 1984
PMID: 6145137
DOI: 10.1016/0149-7634(84)90022-8

Research Context: DSIP molecular identity, animal research, sleep physiology, dose-response characteristics, circadian effects, and early human research.

Acute and Delayed Effects of DSIP on Human Sleep Behavior

Year: 1981
PMID: 6895513

Research Context: Six healthy volunteers, double-blind crossover design, sleep pressure, sleep duration, sleep onset, stage-1 sleep, and sleep efficiency.

Study of Delta Sleep-Inducing Peptide Efficacy in Chronic Insomnia

Year: 1987
PMID: 3583493

Research Context: Controlled insomnia research, polysomnography, NREM sleep, stage-2 sleep, placebo comparison, and limited clinical significance.

Effects of Delta Sleep-Inducing Peptide on Sleep of Chronic Insomniac Patients

Year: 1992
PMID: 1299794

Research Context: Double-blind matched-pairs insomnia study, sleep efficiency, sleep latency, subjective sleep quality, and evidence limitations.

The authors concluded that observed effects were weak and that short-term DSIP treatment was unlikely to produce major therapeutic benefit.

Researchers can review broader DSIP and delta sleep-inducing peptide literature indexed by PubMed for peer-reviewed background research.

Frequently Asked Questions

What is DSIP peptide?

DSIP peptide is a synthetic nine-amino-acid peptide known as Delta Sleep-Inducing Peptide.

What does DSIP stand for?

DSIP stands for:

Delta Sleep-Inducing Peptide

What is the DSIP sequence?

The sequence is:

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

or:

WAGGDASGE

How many amino acids does DSIP contain?

DSIP contains 9 amino acids.

What is the DSIP molecular formula?

The molecular formula is:

C35H48N10O15

What is the molecular weight?

The molecular weight is approximately:

848.82 g/mol

What is the CAS number?

The CAS number is:

62568-57-4

What is the PubChem CID?

The PubChem identifier is:

CID 68816

What are DSIP peptide benefits?

Historical research has investigated sleep, circadian, neuroendocrine, stress, and related pathways, but established human therapeutic DSIP peptide benefits have not been demonstrated.

Does DSIP reliably increase deep sleep?

Not consistently. Controlled studies have produced mixed results, and one insomnia study found no significant improvement in slow-wave sleep.

What is DSIP peptide dosage?

Protide Health does not provide human DSIP peptide dosage instructions. The 10mg value identifies total vial contents only.

What is DSIP dosage?

No human DSIP dosage recommendation is provided. Historical clinical research protocols should not be converted into self-administration instructions.

What does DSIP dosing mean for laboratory research?

Laboratory DSIP dosing should refer to experiment-specific concentrations determined according to validated assay design rather than a human administration schedule.

Is DSIP Reddit information reliable?

DSIP Reddit discussions are anecdotal and cannot establish peptide identity, safety, sleep efficacy, or an appropriate dose.

What about DSIP peptide Reddit reports?

DSIP peptide Reddit experiences may be useful for understanding community discussion but should not replace controlled sleep research or analytical verification.

Is DSIP an approved insomnia medication?

No. DSIP is not an FDA-approved insomnia medication.

What purity does Protide Health specify?

Protide Health specifies 99% purity, with HPLC-MS verification and third-party testing.

Is DSIP intended for human use?

No. DSIP peptide is supplied exclusively for sleep-wake, circadian, neuropeptide, biochemical, molecular, analytical, in-vitro, and qualified preclinical research.

Laboratory Terms & Compliance

Laboratory Research Use Only

This DSIP peptide product is supplied exclusively for laboratory research, sleep-wake physiology studies, circadian research, neuropeptide investigation, analytical testing, biochemical experimentation, molecular studies, in-vitro investigation, and qualified preclinical experimentation.

It is not intended for human or veterinary consumption, insomnia treatment, sleep therapy, pain treatment, withdrawal treatment, medical use, injection, diagnostic use, therapeutic use, or clinical administration.

No human dosage, injection schedule, bedtime protocol, sleep-treatment plan, body-weight calculation, treatment cycle, withdrawal protocol, or human-use preparation guidance is provided.

The purchaser is responsible for appropriate laboratory handling, storage, and use under applicable institutional, federal, state, and local requirements.

For research use only.